

L-Proline Powder is a fermentation-derived, free-form amino acid identified by CAS 147-85-3. Typically supplied as a white to off-white crystalline powder with approximately ≥99% assay, it is suitable for capsules, tablets, nutrition blends and collagen-positioned formulations. Batch documentation, specification review and bulk supply are coordinated according to individual product and procurement requirements.
| Parameter | Typical Specification |
|---|---|
| Product Name | L-Proline Powder |
| Chemical Name | L-Proline; L-pyrrolidine-2-carboxylic acid |
| CAS Number | 147-85-3 |
| Molecular Formula | C5H9NO2 |
| Molecular Weight | 115.13 g/mol |
| Ingredient Category | Free-form amino acid |
| Source and Manufacturing Process | Typically fermentation-derived, purified, crystallized and dried |
| Grade | Food, supplement or formulation grade, as specified |
| Assay | Approximately ≥99%, depending on the approved specification |
| Analytical Method and Reporting Basis | HPLC, titration or another validated method; as-is, dried or anhydrous basis defined in the specification |
| Stereochemical Identity | L-form; optical rotation or equivalent identity testing when applicable |
| Appearance | White to off-white crystalline powder |
| Carrier | Typically carrier-free unless supplied as a custom blend |
| Particle Size | Commonly 80 mesh; alternative specifications subject to confirmation |
| Moisture | Controlled through the approved loss-on-drying specification |
| Solubility | Freely soluble in water; finished-formula performance requires verification |
| Bulk Density and Flowability | Available for capsule filling, powder blending and manufacturing evaluation |
| Origin and Supporting Statements | China or another confirmed origin; relevant allergen, GMO, gluten or vegan statements available when applicable |
| Test Item | Typical Acceptance Criteria |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification | Conforms to the approved identification method |
| Assay | Approximately ≥99% or the agreed product specification |
| Optical Rotation / L-Isomer Identity | Conforms to the approved method and defined test conditions |
| Related Substances | Within the agreed specification |
| Other Amino Acids | Controlled according to the approved impurity profile |
| Chloride | Meets the applicable impurity limit |
| Sulfate | Meets the applicable impurity limit |
| Ammonium | Meets the applicable impurity limit |
| Loss on Drying | Meets the approved moisture specification |
| Residue on Ignition | Meets the approved inorganic residue limit |
| Particle Size | Conforms to the agreed mesh or particle-size requirement |
| Solution Clarity | Conforms when included in the approved testing scope |
| Heavy Metals | Lead, arsenic, cadmium and mercury controlled to the agreed limits |
| Total Plate Count | Meets the approved microbiological specification |
| Yeast and Mold | Meets the approved microbiological specification |
| Escherichia coli | Meets the agreed microbiological requirement |
| Salmonella | Meets the agreed microbiological requirement |
Final testing parameters, analytical methods and optional assessments are established for each approved product specification.
An assay percentage alone does not establish whether two ingredient specifications are equivalent. HPLC and titration can evaluate different analytical characteristics, while results reported on an as-is, dried or anhydrous basis should only be compared when their reporting conditions match. Optical rotation also requires defined test conditions before it can support reliable confirmation of the L-form. Related substances and other amino acids help characterize purification quality, while chloride, sulfate and ammonium provide useful information about process-related impurities. Particle size and moisture affect powder handling, blending consistency and production suitability. Heavy metals and microbiological requirements should reflect the intended application and applicable destination-market standards rather than unrelated competitor specifications. Buyers should also confirm that product identity, assay method, batch number and release documentation remain consistent across the specification, COA and shipping paperwork. Additional testing, including residual solvents or specific microorganisms, should only be included when relevant to the approved project. These controls align with Essencefield’s raw material quality management process.
| Application | Formulation Considerations |
|---|---|
| Capsules | Define the target amount per capsule and assess fill weight, flowability and excipient compatibility. |
| Tablets | Establish the required amount per tablet and evaluate compression behavior, lubrication and disintegration. |
| Nutrition Powders and Sachets | Determine inclusion per serving or pack while checking blend uniformity and moisture protection. |
| Beverage Powders | Evaluate dissolution, solution clarity, flavor compatibility and finished-product stability. |
| Collagen-Positioned Formulations | Assess suitable combinations with complementary amino acids and other formulation ingredients. |
| Gummies and Functional Bars | Review processing temperature, moisture exposure, ingredient interactions and texture. |
Formulation considerations:
Commercial formulation requires matching ingredient characteristics to the complete manufacturing system rather than selecting an inclusion level from unrelated product examples. Powder density, particle size and flowability influence premix uniformity, filling accuracy and the risk of ingredient segregation during transportation. Controlled humidity helps protect handling characteristics before weighing, blending and packaging. In beverage systems, dissolution should be assessed within the final matrix because acidity, minerals, sweeteners and flavor systems can influence performance. Gummies and functional bars require additional evaluation of processing temperature, moisture conditions and interactions with reducing sugars. Where several amino acids are present, preblending lower-inclusion ingredients can improve distribution before incorporation into the full production batch. Free-form L-Proline should not be treated as chemically equivalent to hydroxyproline or collagen peptides, even when these ingredients appear within related product concepts. Appropriate inclusion must be established for each capsule, tablet or serving according to the finished formulation. Commercial release should then follow approved specifications, production records and relevant quality-control results.
| Item | Typical Arrangement |
|---|---|
| Sample and Bulk Packaging | Sealed sample packaging or protective inner packaging within an appropriate drum or carton. |
| Standard Bulk Pack | Commonly 25 kg per drum or carton; alternative formats confirmed individually. |
| Shelf Life | Typically 24–36 months when unopened and stored under recommended conditions. |
| Storage Conditions | Store tightly closed in a cool, dry location away from moisture, heat and direct sunlight. |
| Batch Identification | Product name, lot number and other relevant manufacturing details identified on the label. |
| Shipping Options | Domestic or international shipment coordinated according to destination and order requirements. |
| Export Documentation | Commercial and quality documents supplied according to the shipment and applicable market requirements. |
Final packaging configuration and shelf life should be confirmed against the approved specification and batch documentation.
| Item | Available Information |
|---|---|
| MOQ | Confirmed according to order quantity, packaging and project requirements. |
| Samples | Available for ingredient evaluation and formulation assessment, subject to confirmation. |
| Pilot Quantities | May be arranged for development work or manufacturing trials. |
| Lead Time | Determined by stock availability, testing scope, packaging and shipping destination. |
| Standard Documents | COA, technical data sheet, safety data sheet and product specification. |
| Supporting Statements | Allergen, GMO, gluten, vegan, irradiation or origin documentation when applicable. |
| Suitable Buyers | Supplement brands, formulators, contract manufacturers, importers, distributors and purchasing teams. |
| Quotation Requirements | Intended application, requested quantity, shipping destination, packaging preference and documentation needs. |
MOQ, price and lead time are confirmed individually for each project. Additional procurement coordination is available through Essencefield’s ingredient sourcing services.
Request a quotation for L-Proline Powder to confirm specifications, samples, availability and project-specific supply terms.
Share your target specification, application, quantity and document needs. We will help confirm suitable options, COA/TDS/SDS support and bulk supply details.
Explore related ingredients for formula comparison, complementary applications and alternative sourcing options across food, beverage, supplement and wellness projects.